NCT07311447 (TCI-NEURO) is a clinical trial in Postoperative Cognitive Dysfunction (POCD), sponsored by Namigar Turgut.

Who is sponsoring NCT07311447?

NCT07311447 is sponsored by Namigar Turgut.

What condition does NCT07311447 study?

NCT07311447 studies Postoperative Cognitive Dysfunction (POCD), Neurocognitive Function, Sedation and Analgesia, Geriatric Patients.

Is NCT07311447 still recruiting?

NCT07311447 is currently completed. Last updated 31 December 2025.

Last reviewed 2025-12-31 · How we verify

NCT07311447: TCI-NEURO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Target-Controlled Infusion and Postoperative Neurocognitive Outcomes in Geriatric Patients

Completed Last updated 31 December 2025

What this trial tests

trial in Postoperative Cognitive Dysfunction (POCD) in 50 participants. Completed in 31 October 2025.

Timeline

5 May 2025

Primary endpoint
31 October 2025

31 October 2025

Quick facts

Lead sponsor	Namigar Turgut
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	5 May 2025
Primary completion	31 October 2025
Estimated completion	31 October 2025
Sites	1 location across Turkey (Türkiye)

Conditions studied

Postoperative Cognitive Dysfunction (POCD) — all drugs for Postoperative Cognitive Dysfunction (POCD) →
Neurocognitive Function — all drugs for Neurocognitive Function →
Sedation and Analgesia — all drugs for Sedation and Analgesia →
Geriatric Patients — all drugs for Geriatric Patients →

Sponsor

Namigar Turgut

Who can join

65 and older, any sex, with Postoperative Cognitive Dysfunction (POCD) or Neurocognitive Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational study aims to evaluate the effects of target-controlled infusion (TCI) on postoperative neurocognitive function in geriatric patients undergoing major non-cardiac surgery. Elderly patients are at increased risk of postoperative cognitive dysfunction due to physiological changes and anesthesia-related factors. In this study, sedation management with TCI will be compared to manual infusion. Neurocognitive function will be assessed at multiple time points using the Mini-Mental State Examination (MMSE), and sedation levels will be monitored with the Bispectral Index (BIS) and the Richmond Agitation-Sedation Scale (RASS). The study aims to provide insights into safer sedation practices and improved cognitive outcomes in elderly surgical patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Namigar Turgut trials

Trials by the same sponsor.

NCT04010474 — Surgical APGAR Score and Modified Surgical APGAR Score · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07311447 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Namigar Turgut
Last refreshed: 31 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07311447.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing